DOI: 10.1128/IAI.00495-17
Article Information
PubMed
Published By
History
- Received July 14, 2017
- Returned for modification October 2, 2017
- Accepted December 5, 2017
- Published online February 20, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Nancy E. Freitag, Editor, University of Illinois at Chicago
Article Versions
- Accepted Manuscript version (December 11, 2017).
- You are viewing the most recent version of this article.
Author Information
- Cédric M. Vogta,
- Maria Teresa Armúa-Fernándezb*,
- Kurt Toblera,
- Monika Hilbec,
- Claudio Aguilard,
- Mathias Ackermanna,
- Peter Deplazesb and
- Catherine Eichwalda
- aInstitute of Virology, Vetsuisse, University of Zurich, Zurich, Switzerland
- bInstitute of Parasitology, Vetsuisse, University of Zurich, Zurich, Switzerland
- cLaboratory for Animal Model Pathology, Institute of Pathology, Vetsuisse, University of Zurich, Zurich, Switzerland
- drqmicro Ltd., ETH, Zurich, Switzerland
- Address correspondence to Catherine Eichwald, ceichwald{at}vetvir.uzh.ch.
↵* Present address: Maria Teresa Armúa-Fernández, Laboratorio de Vectores y Enfermedades Transmitidas, Facultad de Veterinaria, CENUR Litoral Norte-Salto-Universidad de la República, Salto, Uruguay.
Citation Vogt CM, Armúa-Fernández MT, Tobler K, Hilbe M, Aguilar C, Ackermann M, Deplazes P, Eichwald C. 2018. Oral application of recombinant Bacillus subtilis spores to dogs results in a humoral response against specific Echinococcus granulosus paramyosin and tropomyosin antigens. Infect Immun 86:e00495-17. https://doi.org/10.1128/IAI.00495-17.
